[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies

April 2012 | 980 pages | ID: F6152023DBFEN
Venture Planning Group

US$ 4,720.00 US$ 5,900.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents a comprehensive analysis of the French infectious disease testing market, including:
  • Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
  • Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in French hospitals, blood banks and commercial laboratories.
  • Instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.
Contains 980 pages and 160 tables.
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. MAJOR INFECTIOUS DISEASE TESTS


1. AIDS
  a. Background
    Structure and Composition
    Classification
    Origin of AIDS
    Animal Lentivirus Systems
    Virus Receptos
    HIV Infections in Humans
      Pathogenesis & Pathology: Overview of HIV Infection Course
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
      Clinical Findings
    Plasma Viral Load
    Pediatric AIDS
      Neurologic Disease
      Opportunistic Infections
      Cancer
    Immunity
      Virus Isolation
      Serology
      Detection of Viral Nucleic Acid and Antigens
    Infectivity
    Epidemiology
      Worldwide Spread of AIDS
      United States
      Routes of Transmission
  b. Diagnostic Tests
    Laboratory Diagnosis
      Enzyme Immunoassay Interpretation
      Specific, Sensitivity, and Predictive Value of Enzyme Immunoassays
    Competition Assays
    Western Blot Technique
    Immuno-Fluorescence Assay (IFA)
    Radioimmunoprecipitation
    HIV-1/HIV-2 Combination Testing
    Methods of HIV-Antigen Detection
    Antigen Assays and Blood Screening
    Urine Tests
    Immunopathogenic Mechanism of HIV Infection
    DNA Probes
      Overview
      Quantitative Polymerase Chain Reaction
      In Situ PCR
      Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Consideration
  c. Vaccines and Drugs
      Antiviral Drugs
      Vaccines Against HIV
    Transmission of HIV in Blood Products
    HIV Transmission in Transplant and Artificial Insemination Recipients
2. Adenovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  d. Adeno-Associated Viruses(AAV)
3. Aeromonas
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
5. Arboviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
6. Babesiosis
  a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
8. Blastocystis Hominis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
9. Brucella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
10. Campylobacter
  a. Background
  b. Diagnostic Tests
    Identification from Culture
  c. Vaccines and Drugs
11. Candida
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
12. Chagas Disease
  a. Background
13. Chancroid
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
14. Chlamydia
  a. Background
    Chlamydia Psittaci
    Chlamydia Pneumoniae
    Chlamydia Trachomatis
  b. Diagnostic Tests
  c. Vaccines and Drugs
15. Clostridium Difficile
  a. Background
    Pediatric Infections
    Epidemiology
  b. Diagnostic Tests
    Counterimmunoelectrophoresis
    Fluorescent-Antibody Assays
    Poloymerase Chain Reactions
  c. Drugs and Vaccines
16. Coronaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
17. Coxsackieviruses
  a. Background
    Herpangina
    Hand-foot-and-mouth syndrome
    Hepidemic Conjuctivitis
    Pharingitis
    Epidemic Pleurodynia
    Myodarditis,Pericarditis
    Overwhelming Infection of the Newborn
    Acute Aseptic Meningitis
    Undifferentiated Febrile Illness
    Fever with upper respiratory infection
    Encephalitis
    Asymptomatic Infection
  b. Diagnostic Tests
  c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
  a. Background
    Blood Transmission
  b. Diagnostic Tests
    Major Commercial and Academic Players
      Bayer
      Disease Sciences/Bio Tec Global
      Imperial College of Medicine
      Ortho-Clinical Diagnostics
      Pall
      ProMetic Life Sciences
      Proteome Sciences/Idexx
      Q-One Biotech
      Serono
      U.S. Agricultural Research Service
  c. Vaccines
19. Cryptosporidium Parvum
  a. Background
  b. Diagnostic Tests
    Histologic
    Laboratory Parasitology
    Serodiagnosis
  c. Vaccines and Drugs
20. Cyclospora Cayetanensis
  a. Background
    Asymptomatic Infection
    Diarrhea in Immunocompetent Persons
    Diarrhea in Immunocompromisedersons
  b. Diagnostic Tests
  c. Vaccines and Drugs
21. Cytomegalovirus
  a. Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
  b. Diagnostic Tests
  c. Vaccines and Drugs
22. Ebola Virus
  a. Background
    Epidemiology
    Hemorrhagic Fever
  b. Diagnostic Tests
  c. Vaccines and Drugs
23. E. Coli
  a. Background
    Role of Escherichia Coli in Causing Diarrhea
    EPEC
    ETEC
    EIEC
    EHEC
  b. Diagnostic Tests
  c. Vaccines and Drugs
24. EchoVirus
  a. Background
    Acute Aseptic Miningitisis
    Encephalitis
    Exanthems
    Respiratory Disease
    Myope;ricarditis
    Neonatal Infections
  b. Diagnostic Tests
  c. Vaccines and Drugs
25. Encephalitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
26. Enteroviruses
  a. Background
  b. Diagnostic Tests
    Viral Isolation and Identification
    Antibody Tests
  c. Vaccines and Drugs
27. Epstein-Barr Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
28. Giardia Lamblia
  a. Background
    Life Cycle and Morphology
    Morphology of Trophozoites
    Clinical Disease
  b. Diagnostic Tests
  c. Vaccines and Drugs
29. Gonorrhea
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
30. Granuloma Inguinale
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
31. Hantavirus
  a. Background
    Identification of the Agent
    Transmission
    Other Rodent Hantaviruses
    Distribution
    Hantavirus Diseases
    Epidemiology
    Addendum in Proof-Northeastern Connection
    Previously Unknown Pathogens
    Cases Nationwide
  b. Diagnostic Tests
    An Immunohistochemistry Approach
    Hantavirus Rapid Diagnostic Test
    ELISA Diagnosis of Hantavirus Pulmonary Syndrome
    IgG ELISA
    IgM Capture ELISA
  c. Vaccines and Drugs
32. Helicobacter Pylori
  a. Background
    Pathogenesis
    Role in Peptic Ulcer Disease
    Role in Gastric Cancer
    Nonulcer Dyspepsia
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Specific Therapeutic Regimens
    Who Should Be Treated?
    Participants in Controlled Clinical Trials
    Patients with Refractory Peptic Ulcer
    Patients with Refractory NUD
    Patients in High-Risk Groups for Gastric Cancer
33. Hepatitis
  a. Background
  b. Hepatitis A
  c. Hepatitis B
  d. Hepatitis C
    Classification
    Transmission of Infection
    Occupational Hazards
    Acute Hepatitis
    Diagnosis of Acute Infection
    Chronic Hepatitis
    HCV and Other Chronic Liver Diseases
    Alcoholic Liver Disease
    Hepatitis B Coinfection
    Cirrhosis and Hepatocellular Carcinoma
    Diagnostic Tests
    Possible Indications for HCV RNA Testing
    Conclusions and Future Direction
  e. Hepatitis D
    Historical Perspective
    Epidemiology
    HBV-HDV ""Coinfection"" vs. ""Superinfection""
    Methods of Detecting HDV
    Prevention
  f. Hepatitis E
    Background
    Prevalence of the Disease
    Diagnostic Tests
    Epidemiologic Serosurveys
    Serologic Cross-Reactivity
  g. Hepatitis G
    Vaccines and Drugs
34. Herpes Simplex Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
  a. Background
    HIV-6 Infections
  b. Diagnostic Tests
  c. Vaccines and Drugs
36. Influenza Viruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
37. Legionella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
38. Lyme Disease
  a. Background
    Clinical Description
    Clinical Case Definition
    Laboratory Criteria for Diagnosis
    Case Classification
  b. Diagnostic Tests
  c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
40. Malaria
  a. Background
  b. Diagnostic Tests
    Potential Diagnositic Problems with Positive Patients from Non-endemic Areas
      Patient
      Laboratory
      Physician
  c. Vaccines and Drugs
41. Measles (Rubeola)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
42. Meningitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Development of Polysaccharide Vaccines
    Quadrivalent Vaccine Development
    Meningococcal A.C.Y. & W-135 Vaccines
    Efficacy of Group C Vaccine
    Efficacy of Group A Vaccine
    Combinations of Group A and C Vaccines
    Group B Efficacy Trials
    Future Direction
43. Microsporidium
  a. Background
    Prevalence and Geographic Distribution
    Sources of Human Infection and Transmission
  b. Diagnostic Tests
    Light Microscopic Examination of Stool Specimens By Chromotrope Staining
    Stool Concentration Methods
    Chemofluorescent Agents
    Giemsa Staining of Stool Specimens
    Cytologic Diagnosis
    Histologic Examination
    Electron Microscopy
    Examination of Bodily Fluids
    Examination of Tissue Sections
    Immunofluorescence Detection Procedures
    Serology
    Cell Culture
    Approach to Diagnosis
    Evaluation of Patients with Presumptive Intestinal Microsporidiosis
    Evaluation of Patients with Presumptive Ocular Microsporidiosis
  c. Vaccines and Drugs
44. Mononucleosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
45. Mumps
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Efficacy of Vaccination
    Future Issues
46. Mycoplasma
  a. Background
    Ureaplasma Urealyticum & Mycoplasma Hominis
  b. Diagnostic Tests
  c. Vaccines and Drugs
47. Papillomaviruses
  a. Background
    HPV in Cancer
    Cervical Neoplasm
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Prevention
48. Parvovirus B19
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
49. Pneumonia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
50. Polyomaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
  a. Background
    Virulence Factors
  b. Diagnostic Tests
  c. Vaccines and Drugs
52. Rabies
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
54. RhinoViruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
56. Rubella(MEASLES)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Developing Countries
    Elimination and Eradication of Measles
    New Developments
57. Salmonellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
58. Septicemia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
59. Shigellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
60. Staphylococcus Aureus
  a. Background
    The Genus Taphylococcus
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Prevention
61. Streptococci
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
    Group A Streptococci
    Group B Streptococci
62. Syphilis
  a. Background
  b. Diagnostic Tests
    Biopsy
    Rabbit Infectivity Testing
    Other Diagnostic Modalities
  c. Vaccines and Drugs
    Syphilis and HIV Infection
    Syphilis As a Cofactor for HIV Transmission
    Basic Science Issues
63. Toxoplasmosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
64. Trichomonas Vaginalis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
65. Tuberculosis
  a. Background
  b. Diagnostic Tests
    Microscopic Characteristics
    Cultural Characteristics
    Detection of Antibodies
    Skin Tests
    MDRTB
  c. Vaccines and Drugs
66. Vibrio
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
67. West Nile Virus
  a. Background
      Clinical Syndromes
  b. Diagnostic Tests
  c. Vaccines and Drugs
68. Yersina
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs

B. INSTRUMENTATION REVIEW AND MARKET NEEDS

Abbott AxSYM
Abbott IMx/IMx Select
Anagen AN2000/AuraFlex
Siemens Immuno 1
Beckman Coulter Access
BioChem Pharma/SR1
BioMerieux/Vitek Vidas
Biotrol System 7000
Chiron ACS: Centaur
Chiron ACS: 180
Siemens ELISA Processor II/III
Siemens/Opus/Plus/Magnum
Siemens Stratus
J&J Diagnostics Vitros ECi
J&J Diagnostics/Amersham Amerlite
Olympus PK310
Roche Elecsys 1010/2010
Roche Cobas Core
Roche ES 300/300AL
Roche ES 22
Roche ES 33
Tosoh AIA-1200/1200DX/NexIA/600
Wallac/Pharmacia Delfia

C. EMERGING DIAGNOSTIC TECHNOLOGIES

1. DNA Probes
  a. Technology Overview
  b. Amplification Methods
    Polymerase Chain Reaction
      Robotics
      Temperature Cyclers
      PCR Variations
    Immuno-PCR
    QC-PCR
    DAP-PCR
    Ligase Chain Reaction
    Branched DNA
    Q-Beta Replicase
    Nucleic-Acid Sequence-Based
    Strand Displacement Activation
    Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
  a. Technological Principle
  b. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    Dot Immunobinding Assays
    Capillary Immunoassays
    Particle-Membrane Capture Immunoassays
    Enzyme Amplification
  c. Fluorescent Immunoassays
    Fluorescence Polarization
    Time-Resolved Pulse Fluorescence
  d. Luminescence
    Chemiluminescence
    Bioluminescence
  e. Latex Agglutination
  f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other

D. PERSONAL TESTING

E. WORLDWIDE BUSINESS ENVIRONMENT

F. WORLDWIDE MARKET STRUCTURE

G. WORLDWIDE MARKET SIZE AND GROWTH


FRANCE

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES


A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized

TESTING MARKETS

1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Applera
Beckman Coulter
Becton Dickinson
Binding Site
Biomerica
Biokit
bioMerieux
Bio-Rad
Biotrol
Biosite
Biotest
Caliper Technologies
Cepheid
Chemicon
Daiichi
DiaSorin
Diagast
Diamedix
Digene
Eiken
Enzo Biochem
Fujirebio
GenBio
Gene-Tec
Hemagen
Immunetics
Innogenetics
Inverness
J&J
Meridian
Nanogen
Nissui
Olympus
Provalis
Roche
Saliva Diagnostic
SeraCare
Siemens
Third Wave Technologies
Thermo Fisher
Tosho
Trinity Biotech
Tropix
Wampole Labs
Zenith
Zeus

Appendix: Assumed Currency Exchange Rates

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories Performing Infectious Disease Tests by Country
Worldwide All Market Segments Total Infectious Disease Test Volume Forecast by Country
Worldwide All Market Segments Total Infectious Disease Diagnostics Market Forecast by Country
Infectious Disease Tests Major Issues and Market Potential For Personal Testing
France Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
France Laboratories Performing Infectious Disease Tests by Market Segment
France Hospital Laboratories Performing Infectious Disease Tests by Bed Size
France Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
France All Market Segments Infectious Disease Test Volume Forecast
France Hospital Laboratories Infectious Disease Test Volume Forecast
France Blood Banks Infectious Disease Test Volume Forecast
France Commercial/Private Laboratories Infectious Disease Test Volume Forecast
France All Market Segments Infectious Disease Diagnostics Market Forecast
France Hospital Laboratories Infectious Disease Diagnostics Market Forecast
France Blood Banks Infectious Disease Diagnostics Market Forecast
France Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
France HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast Forecast by Market Segment
France HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
France HIV Ag Test Volume and Diagnostics Sales Forecast by Market Segment
France Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
France Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
France BEA Test Volume and Diagnostics Sales Forecast by Market Segment
France Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
France Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
France Candida Test Volume and Diagnostics Sales Forecast by Market Segment
France Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
France Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
France Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
France CMV Test Volume and Diagnostics Sales Forecast by Market Segment
France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
France Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France EBV Test Volume and Diagnostics Sales Forecast by Market Segment
France Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
France Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
France Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
France Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
France HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
France Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
France Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
France Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
France Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
France Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
France HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
France HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
France Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
France Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
France Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
France Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
France Measles Test Volume and Diagnostics Sales Forecast by Market Segment
France Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
France Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
France Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
France Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
France Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
France Polioma Viruses Test Volume and Diagnostics Sales Forecast by Market Segment
France Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
France Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
France RSV Test Volume and Diagnostics Sales Forecast by Market Segment
France Rheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment
France Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
France Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
France Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
France Scleroderma Test Volume and Diagnostics Sales Forecast by Market Segment
France Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
France Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
France Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
France Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
France Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
France Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
France Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
France Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
France AIDS Testing Market Diagnostics Sales by Major Supplier
France Adenovirus Testing Market Diagnostics Sales by Major Supplier
France Campylobacter Testing Market Diagnostics Sales by Major Supplier
France Candida Testing Market Diagnostics Sales by Major Supplier
France Chlamydia Testing Market Diagnostics Sales by Major Supplier
France CMV Testing Market Diagnostics Sales by Major Supplier
France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France Hepatitis Testing Market Diagnostics Sales by Major Supplier
France Hepatitis C Testing Market Diagnostics Sales by Major Supplier
France Herpes Testing Market Diagnostics Sales by Major Supplier
France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
France Meningitis Testing Market Diagnostics Sales by Major Supplier
France Mononucleosis Testing Market Diagnostics Sales by Major Supplier
France Mumps Testing Market Diagnostics Sales by Major Supplier
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
France RSV Testing Market Diagnostics Sales by Major Supplier
France Rheumatoid Arthritis Testing Market Diagnostics Sales by Major Supplier
France Rotavirus Testing Market Diagnostics Sales by Major Supplier
France Rubella Testing Market Diagnostics Sales by Major Supplier
France Septicemia Testing Market Diagnostics Sales by Major Supplier
France Shigella Testing Market Diagnostics Sales by Major Supplier
France Streptococci Testing Market Diagnostics Sales by Major Supplier
France Syphilis Testing Market Diagnostics Sales by Major Supplier
France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
France Trichomonas Testing Market Diagnostics Sales by Major Supplier
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
France Infectious Disease Diagnostic Testing Instrumentation
Major Systems Estimated Placements and Installed Base


More Publications